Tumor suppressor PTEN affects tau phosphorylation: Deficiency in the phosphatase activity of PTEN increases aggregation of an FTDP-17 mutant Tau

Molecular Neurodegeneration

Volumn 1, Issue 1, 2006, Pages

  Zhang, Xue ^a   Zhang, Yun Wu ^a   Liu, Shijie ^a   Bulloj, Ayelen ^a   Tong, Gary G ^a   Zhang, Zhuohua ^a   Liao, Francesca Fang ^a   Xu, Huaxi ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248353520     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-1-7     Document Type: Article

References (59)

1. Trojanowski JQ, Lee VM: "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann N Y Acad Sci 2000, 924:62-67.
2. Lee VM, Goedert M, Trojanowski JQ: Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24:1121-1159.
3. Morsch R, Simon W, Coleman PD: Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neural 1999, 58:188-197.
4. Zheng H, Koo EH: The amyloid precursor protein: beyond amyloid. Mol Neurodegeneration 2006, 1:.
5. Vetrivel KS, Zhang Y, Xu H, Thinakaran G: Pathological and physiological functions of presenilins. Mol Neurodegeneration 2006, 1:.
6. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubuleassociated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Notl Acad Sci U S A 1986, 83:4913-4917.
7. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW: A protein factor essential for microtubule assembly. Proc Natl Acad Sci U SA 1975, 72:1858-1862.
8. Cleveland DW, Hwo SY, Kirschner MW: Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 1977, 116:207-225.
9. Cleveland DW, Hwo SY, Kirschner MW: Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 1977, 116:227-247.
10. Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E: Abnormal Alzheimer-like phosphorylation of tauprotein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 1993, 336:417-424.
11. Hanger DP, Hughes K, Woodgett J R, Brion JP, Anderton BH: Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 1992, 147:58-62.
12. Roder HM, Ingram VM: Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci J 1991, 11:3325-3343.
13. Roder HM, Eden PA, Ingram VM: Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease, Biochem Biophys Res Commun 1993, 193:639-647.
14. Robertson J, Loviny TL, Goedert M, Jakes R, Murray KJ, Anderton BH, Hanger DP: Phosphorylation of tau by cyclic-AMP-dependent protein kinase. Dementia 1993, 4:256-263.
15. Baudier J, Cole RD: Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J Biol Chem 1987, 262:17577-17583.
16. Baudier J, Lee SH, Cole RD: Separation of the different microtubule-associated tau protein species from bovine brain and their mode II phosphorylation by Ca2+/phospholipiddependent protein kinase C. J Biol Chem 1987, 262:17584-17590.
17. Ksiezak-Reding H, Pyo HK, Feinstein B, Pasinetti GM: Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro, Biochem Biophys Acto 2003, 1639:159-168.
18. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-lqbal I: Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 1993, 268:24374-24384.
19. Kenessey A, Yen SH: The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res 1993, 629:40-46.
20. Alonso AC, Zaidi T, Grundke-lqbal I, Iqbal K: Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Notl Acad Sci U S A 1994, 91:5562-5566.
21. Alonso A, Zaidi T, Novak M, Grundke-lqbal I, Iqbal K: Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Notl Acad Sci U S A 2001, 98:6923-6928.
22. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JB, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P: Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
23. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg G D: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neural 1998, 43:815-825.
24. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Notl Acad Sci U S A 1998, 95:7737-7741.
25. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, O'Connor R, O'Neill C: Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 2005, 93:105-117.
26. Li X, An WL, Alafuzoff I, Soininen H, Winblad B, Pei JJ: Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain. Neuroreport 2004, 15:2237-2240.
27. An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B. Peil JJ: Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am J Pathol 2003, 163:591-607.
28. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB: TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model. Cur r Biol 2006, 16:230-241.
29. Stiles B, Groszer M, Wang S, Jiao J, Wu H: PTENIess means more. Dev Biol 2004, 273:175-184.
30. Sulis ML, Parsons R: PTEN: from pathology to biology. Trends Cell Biol 2003, 13:478-483.
31. Stokoe D: Pten. Curr Biol 2001, 11:R502.
32. Li DM, Sun H: TEPI, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997, 57:2124-2129.
33. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
34. Steck PA, Pershouse MA, Jasser SA, YungWK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Not Genet 1997, 15:356-362.
35. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMACI, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998, 273:13375-13378.
36. Cantley LC, Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Notl Acad Sci U S A 1999, 96:4240-4245.
37. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Not Genet 1998, 19:348-355.
38. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Notl Acod Sci U S A 1999, 96:1563-1568.
39. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
40. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998, 8:1169-1178.
41. Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ: Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Not Genet 2001, 29:404-411.
42. Fraser MM, Zhu X, Kwon CH, Uhlmann EJ, Gutmann DH, Baker SJ: Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Concer Res 2004, 64:7773-7779.
43. Zhang X, Li F, Bulloj A, Zhang Y, Tong G, Zhang Z, Liao F, Xu H: Tumor suppressor PTEN affects tau phosphorylation, aggregation and binding to microtubules. FASEB J 2006, In Press:.
44. Perez M, Lim F, Arrasate M, Avila J: The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J Neurochem 2000, 74:2583-2589.
45. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ, Lee VM: Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 2000, 11:4093-4104.
46. Reed LA, Grabowski TJ, Schmidt ML, Morris JC, Goate A, Solodkin A, Van Hoesen GW, Schelper RL, Talbot CJ, Wragg MA, Trojanowski JQ: Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 1997, 42:564-572.
47. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK: The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Notl Acad Sci USA 1998, 95:13513-13518.
48. Wang X, Gjorloff-Wingren A, Saxena M, Pathan N, Reed JC, Mustelin T: The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase. J Immunol 2000, 164:1934-1939.
49. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX: Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 2005, 22:1942-1950.
50. Illenberger S, Zheng-Fischhofer Q, Preuss U, Stamer K, Baumann K, Trinczek B, Biernat J, Godemann R, Mandelkow EM, Mandelkow E: The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell 1998, 9:1495-1512.
51. Weng LP, Brown JL, Baker KM, Ostrowski MC, Eng C: PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet 2002, 11:1687-1696.
52. Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, Takashima A: Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Notl Acad Sci U S A 2002, 99:13896-13901.
53. Gotz J, Chen F, Barmettler R, Nitsch RM: Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001, 276:529-534.
54. Lim F, Hernandez F, Lucas JJ, Gomez-Ramos P, Moran MA, Avila J: FTDP-17 mutations in tau transgenic mice provoke Iysosomal abnormalities and Tau filaments in forebrain. Mol Cell Neurosci 2001, 18:702-714.
55. Gotz J, Tolnay M, Barmettler R, Chen F, Probst A, Nitsch RM: Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur J Neurosci 2001, 13:2131-2140.
56. Matsumura N, Yamazaki T, Ihara Y: Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontote m poral dementia and parkinsonism linked to chromosome 17 (FTDP-17). Am J Pothol 1999, 154:1649-1656.
57. Mack TG, Dayanandan R, Van Slegtenhorst M, Whone A, Hutton M, Lovestone S, Anderton BH: Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells. Neuroscience 2001, 108:701-712.
58. DeTure M, Ko LW, Easson C, Yen SH: Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau. Am J Pathol 2002, 161:1711-1722.
59. Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, Gouras GK, Greengard P, Xu H: Chaperones increase association of tau protein with microtubules. Proc Notl Acad Sci U S A 2003, 100:721-726.